Free tool

Cell therapy stocks

We cover 25 companies grouped under the Cell therapy theme. The median market value in the group is $21.68M. Across the group, the median move over the past trading day is −1.18%. 36% of the 25 with a 200-day average trade above it. Price change over the past year runs from −85.7% to +1.4% across the middle 80 percent of the group, with a median of −44.3%.

Other lists in this group

Table

25 of 86 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
LEGNLegend Biotech Corporation$4.02BMid cap−40.44%
IOVAIovance Biotherapeutics, Inc.$3.66BMid cap+233.88%
MESOMesoblast Limited$2.23BMid cap+4.47%
VCELVericel Corporation$2.17BMid cap+18.25%
ATRAAtara Biotherapeutics, Inc.$94.15MMicro cap−24.05%
ACETAdicet Bio, Inc.$83.79MMicro cap−26.01%
INKTMiNK Therapeutics, Inc.$60.16MMicro cap−26.22%
TCRXTScan Therapeutics, Inc.$50.80MMicro cap−58.43%
TVGNTevogen Inc.$43.63MMicro cap−85.43%
CCELCryo-Cell International, Inc.$34.67MMicro cap−3.19%
ESLAEstrella Immunopharma, Inc.$31.75MMicro cap−22.34%
SVA.TOSernova Biotherapeutics Inc$29.93MMicro cap−42.11%
LGVNLongeveron Inc.$21.68MMicro cap−14.44%
NCELNewcelX Ltd.$19.52MMicro cap−84.77%
BCDABioCardia, Inc.$18.02MMicro cap−38.66%
PLURPluri Inc.$17.91MMicro cap−69.17%
SNTISenti Biosciences Holdings, Inc.$12.03MMicro cap−75.23%
INABIN8bio, Inc.$11.68MMicro cap−48.03%
GDTCCytoMed Therapeutics Limited$11.06MMicro cap−50.41%
FBLGFibroBiologics, Inc.$9.39MMicro cap−88.25%
CELZCreative Medical Technology Holdings, Inc.$7.85MMicro cap−63.27%
PMCBPharmaCyte Biotech, Inc.$5.80MMicro cap−44.28%
ERNAErnexa Therapeutics Inc.$5.70MMicro cap−85.93%
BRTXBioRestorative Therapies, Inc.$5.67MMicro cap−86.10%
MBIOMustang Bio, Inc.$4.24MMicro cap−63.40%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse